|
End-of-day quote
Other stock markets
|
||
| - LVL | - |
|
| 07/01/22 | Delisting of AS "Olainfarm” shares from the Baltic Main list | AQ |
| 06/01/22 | Notification about results of final buy-back of shares | AQ |
| 30/12/21 | Notification about final share buy-back | AQ |
| 28/12/21 | Correction: Regarding results of a share buy-back offer | AQ |
| 28/12/21 | On substantial participation (4) - specified | AQ |
| Manager | Title | Age | Since |
|---|---|---|---|
Juris Hmelnickis
CEO | Chief Executive Officer | 46 | 01/01/2026 |
Janis Leimanis
DFI | Director of Finance/CFO | 56 | - |
| Chief Tech/Sci/R&D Officer | - | 01/01/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Janis Buks
CHM | Chairman | - | 01/09/2022 |
| Director/Board Member | 63 | 19/06/2021 | |
Vadims Telica
BRD | Director/Board Member | 62 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.81% | +2.25% | +13.63% | +81.62% | 48B | |
| -2.54% | +3.72% | +66.86% | +116.52% | 36.89B | |
| +0.15% | +1.26% | -3.64% | +44.11% | 12.37B | |
| +3.71% | +3.56% | +13.95% | +98.68% | 11.95B | |
| +0.39% | +0.58% | +32.90% | +120.94% | 9.01B | |
| +0.66% | -0.57% | +19.74% | +46.69% | 7.2B | |
| +0.71% | +1.75% | +52.67% | -6.28% | 7.05B | |
| +9.99% | +32.94% | -15.50% | +25.64% | 6.58B | |
| +0.68% | +2.63% | +20.79% | +240.34% | 6.55B | |
| Average | +1.73% | +4.24% | +22.38% | +85.36% | 16.18B | |
| Weighted average by Cap. | +0.84% | +3.35% | +28.07% | +89.74% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- OLF1R Stock
- OLF1R Stock
Select your edition
All financial news and data tailored to specific country editions
